Skip to main content

Table 1 Baseline characteristics of study participants according to TATp2-1 tertiles

From: A retrospective cohort analysis of plasma TAT level trends and adverse pregnancy outcomes in early pregnancy patients with newly diagnosed VTE

Characteristics

Low

Middle

High

P-value

N

30

29

30

 

Demographics

Age (years, mean ± SD)

32.3 ± 4.2

34.9 ± 4.9

33.7 ± 5.4

0.156

BMI (kg/m², mean ± SD)

26.8 ± 3.7

26.9 ± 3.1

27.4 ± 4.1

0.715

Education level (n, %)

University

24 (80.0)

25 (86.2)

23 (76.7)

0.678

High school

5 (16.7)

4 (13.8)

5 (16.7)

0.998

Middle school

1 (3.3)

0 (0.0)

2 (6.7)

0.245

Obstetric history (n, %)

Primigravida

13 (43.3)

8 (27.6)

10 (33.3)

0.145

Delivery method (n, %)

Vaginal

16 (53.3)

18 (62.1)

17 (56.7)

0.823

Cesarean

14 (46.7)

11 (37.9)

13 (43.3)

0.754

Pregnancy complications (n, %)

Gestational diabetes

3 (10.0)

9 (31.0)

7 (23.3)

0.136

Gestational hypertension

2 (6.7)

1 (3.4)

3 (10.0)

0.868

Pre-eclampsia

1 (3.3)

5 (17.2)

0 (0.0)

0.015

Uterine fibroids

6 (20.0)

7 (24.1)

6 (20.0)

0.905

Medical conditions (n, %)

Thrombophilia

10 (33.3)

8 (27.6)

8 (26.7)

0.828

Thyroid diseases

2 (6.7)

5 (17.2)

3 (10.0)

0.423

Assisted reproduction

1 (3.3)

5 (17.2)

5 (16.7)

0.182

Pregnancy outcome (n, %)

Abnormal pregnancy

8 (26.7)

13 (44.8)

22 (73.3)

0.001

  1. TATp2-1 = the difference between second trimester TAT level and first trimester TAT level. BMI = Body Mass Index